Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amedisys Inc - Common Stock (NQ:AMED)

100.99 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amedisys Inc - Common Stock

< Previous 1 2 3 4 5 Next >
UnitedHealth Group's Tumultuous Quarter: A Bellwether for Healthcare Payer Crisis
The healthcare payer industry is reeling following a challenging second quarter, epitomized by UnitedHealth Group's (NYSE: UNH) significant earnings miss and the deepening shadow of a federal Medicare... 
Via MarketMinute
Topics Earnings Economy Fraud
UnitedHealth Group Under Siege: DOJ Probes and Cyberattack Aftermath Shake Healthcare Giant
UnitedHealth Group (NYSE: UNH), a dominant force in the U.S. healthcare landscape, is currently embroiled in an unprecedented storm of regulatory and legal scrutiny. Federal Justice Department probes... 
Via MarketMinute
Topics Economy Lawsuit
DOJ Requires Broad Divestitures, $1.1M Fine To Resolve UnitedHealth-Amedisys Merger Challenge: Retail Thinks It May Reduce Expected Synergies
Via Stocktwits
Why UnitedHealth Stock Is Down Today
Via The Motley Fool
Is NASDAQ:AMED suited for quality investing?
AMEDISYS INC (NASDAQ:AMED) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
Why Is UnitedHealth Stock Trading Higher Friday?
UnitedHealth shares jump after Buffett and Burry invest, despite earnings miss and DOJ settlement in $3.3 billion Amedisys deal. 
Via Benzinga
Topics Earnings
UnitedHealth Group Climbs 1.17% After Hours Following $2.21 Quarterly Dividend Authorization
UnitedHealth stock rose after-hours on a new dividend announcement but remains down over 50% from last year. 
Via Benzinga
What's Going On With UnitedHealth Stock Monday?
UnitedHealth will sell 164 healthcare facilities in a DOJ settlement over its Amedisys deal while missing Q2 earnings and reaffirming 2025 guidance. 
Via Benzinga
UnitedHealth Faces Large Outpatient Divestiture To Resolve Antitrust Suit Related To Amedisys Deal
UnitedHealth will divest 164 healthcare locations and Amedisys will pay a $1.1 million penalty under a DOJ settlement resolving antitrust concerns over a $3.3 billion deal. 
Via Benzinga
Amedisys (AMED) Q2 Revenue Tops 5%
Via The Motley Fool
Home Health Braces For Potential $1 Billion Cut In Medicare Payments
The Centers for Medicare & Medicaid Services (CMS) released a proposed rule on Monday outlining changes to how Medicare pays home health agencies (HHAs) in calendar year (CY) 2026. These updates are... 
Via Benzinga
3 Stocks to Gain From Trump’s Family Caregiver Tax Credits
President Trump has spoken about implementing a family caregiver tax credit during his presidential campaign to ease the burden on caregivers, here's who gains. 
Via MarketBeat
Topics Government
UnitedHealth Group Q4 Earnings Preview: First Report Since Insurance CEO's Murder Comes With Questions On Company's Future
UnitedHealth shares a quarterly report for the first time since the death of insurance unit leader Brian Thompson. A look at the estimates and key items to watch. 
Via Benzinga
UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
 
Via Benzinga
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Amedisys and UnitedHealth extend their $3.3B merger deadline to 2025, amid DOJ scrutiny over competition concerns in the home health market. 
Via Benzinga
Amedisys, Rigetti Computing And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
What's Going On With UnitedHealth Stock?
UnitedHealth shares have declined 5.3% over the past week. The company faces a significant legal challenge to its $3.3 billion acquisition of Amedisys. 
Via Benzinga
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to VitalCaring, aims to balance growth and competition. 
Via Benzinga
Justice Department Moves To Block UnitedHealth's Amedisys Takeover: What's Going On?
UnitedHealth Group Inc (NYSE:UNH) shares are trading lower Tuesday. The U.S. Justice Department is moving to block the company's multi-billion acquisition of Amedisys Inc (NASDAQ:AMED). 
Via Benzinga
Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers 
From Amedisys, Inc.
Via GlobeNewswire
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024
AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024
AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay. 
Via InvestorPlace
3 Stocks To Turn $1,000 Into $10,000 in 10 Years
There are a few simple rules for investing for 10x returns but they are among the most difficult to follow. 
Via InvestorPlace
3 Stocks Profiting from America’s Long-Term Care Crisis
These long-term care stocks provide older Americans with the care they need and the income to pay for it well into retirement. 
Via InvestorPlace
Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know
 
Via Benzinga
The 3 Best Stock Picks for This Week
The best stock picks for this week have long-term aims such as high earnings and growth for your portfolio. 
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.